Trust signals
> Reviewed by FormBlends Medical Team · Last updated May 2026 · 11 sources cited · As of May 2026, confirm directly with your plan
Key Takeaways
- Tricare covers Zepbound through the Tricare Pharmacy Program administered by Express Scripts
- The December 2024 FDA approval of tirzepatide for moderate-to-severe OSA created a separate coverage pathway
- Active duty service members face additional operational readiness considerations
- Mounjaro coverage for type 2 diabetes is more accessible than Zepbound for obesity-only diagnoses
- Tricare for Life beneficiaries coordinate Medicare Part D with Tricare wraparound, complicating coverage
Direct answer
Tricare covers Zepbound for eligible beneficiaries through the Tricare Pharmacy Program with prior authorization. Coverage requires BMI documentation, comorbidities, and failed lifestyle intervention for the obesity indication, or polysomnography and CPAP trial documentation for the OSA indication (added December 2024). Active duty service members face additional readiness considerations. Cost-sharing depends on beneficiary category and pharmacy choice. Verify with Tricare and Express Scripts directly.
See transparent compounded pricing
Review compounded GLP-1 pricing and what provider-reviewed care includes, with no surprises at checkout.
Try the Cost Calculator →Table of contents
- How Tricare pharmacy benefits work
- Beneficiary categories and Zepbound access
- Tricare PA criteria for obesity indication
- The December 2024 OSA pathway
- Active duty service member considerations
- Mounjaro coverage for diabetic members
- Pharmacy options and cost-sharing
- Tricare for Life and Medicare Part D coordination
- Humana Military and other regional administrators
- Appealing a Tricare denial
- Decision framework
- FAQ
- Sources
How Tricare pharmacy benefits work
The Tricare Pharmacy Program serves approximately 9.5 million beneficiaries across active duty, retirees, and dependents. The Defense Health Agency manages the overall Tricare program; Express Scripts holds the Tricare Pharmacy Program contract administering pharmacy benefits.
Key components:
- The Tricare Uniform Formulary, determined by the DoD Pharmacy and Therapeutics Committee
- Tricare Pharmacy Home Delivery (Express Scripts mail order)
- Military Treatment Facility pharmacies
- Tricare retail pharmacy network
- Prior authorization processing through Express Scripts
The DoD P&T Committee sets formulary placement and PA criteria. Express Scripts administers per the DoD specification.
Beneficiary categories and Zepbound access
Tricare beneficiaries fall into several categories with different cost-sharing and access patterns:
- Active duty service members
- Active duty family members
- Military retirees and their dependents
- Tricare for Life (Medicare-eligible retirees with wraparound coverage)
- Tricare Reserve Select (drilling reservists)
- Survivors and other categories
All categories have access to Zepbound coverage subject to PA criteria. Cost-sharing differs across categories.
Tricare PA criteria for obesity indication
Tricare PA for Zepbound for obesity typically requires:
- BMI 30 or higher, or BMI 27 with weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, OSA)
- Documentation of failed lifestyle intervention, typically 6 months of structured weight-management program participation
- Absence of contraindications (personal or family history of medullary thyroid carcinoma, MEN 2)
- Documentation of medical necessity by prescribing clinician
- Sometimes, prior trial of preferred GLP-1 alternative
Initial PA approval is typically 6 months, with reauthorization requiring documented weight loss of approximately 5% from baseline.
The December 2024 OSA pathway
The FDA's December 2024 approval of tirzepatide (Zepbound) for moderate-to-severe obstructive sleep apnea in adults with obesity, based on the SURMOUNT-OSA trials, has been incorporated into Tricare coverage policy.
For Tricare beneficiaries, the OSA indication provides an alternative pathway. Coverage criteria typically include:
- Polysomnography documenting moderate-to-severe OSA (AHI 15 or higher)
- BMI 30 or higher
- Documentation of CPAP intolerance, insufficiency, or contraindication
- Sleep medicine physician documentation
For active duty service members with OSA, this pathway is particularly relevant because OSA can affect operational readiness through sleep quality, daytime alertness, and physical fitness. Effective OSA treatment supports duty performance.
Active duty service member considerations
Active duty service members face considerations that civilian patients do not encounter:
Operational readiness: Service members must meet specific fitness standards. Service-specific programs include the Army Combat Fitness Test, Navy and Marine Corps body composition standards, and Air Force Body Composition Assessment Program. Medication use intersects with these standards.
Deployment considerations: Medications requiring refrigeration, regular injection, or close monitoring can complicate deployment. Service members should discuss deployment implications with command medical officer.
Command medical officer coordination: Service members should ensure their command medical officer is aware of medication use, particularly for medications that could affect duty performance.
Performance and physical fitness: The temporary nausea and GI effects during titration could affect physical fitness testing. Service members should plan medication initiation around fitness testing schedules.
Zepbound is not on the DoD list of prohibited medications. Use is permitted, but coordination with command medical authorities is appropriate.
Mounjaro coverage for diabetic members
Tirzepatide is marketed as Mounjaro for type 2 diabetes and as Zepbound for obesity and OSA. Same molecule, different brand label, different indication.
For Tricare beneficiaries with type 2 diabetes, Mounjaro coverage is substantially more accessible than Zepbound coverage. Tricare PA for Mounjaro typically requires:
- Documented type 2 diabetes diagnosis
- A1c value documented within 6 months
- Prior trial of metformin or contraindication
- Step therapy in some PA frameworks
Members with both type 2 diabetes and obesity who need tirzepatide should typically be prescribed Mounjaro under the diabetes indication.
Pharmacy options and cost-sharing
Tricare beneficiaries can fill prescriptions through multiple pathways:
| Pharmacy option | Cost (non-active duty) |
|---|---|
| Military Treatment Facility pharmacy | $0 for formulary medications |
| Tricare Pharmacy Home Delivery (90-day) | ~$14 generic, ~$38 brand formulary, ~$76 brand non-formulary |
| Tricare network retail (30-day) | ~$16 generic, ~$43 brand formulary, ~$76 brand non-formulary |
| Out-of-network retail | Higher with partial reimbursement |
Active duty service members pay $0 at all Tricare network pharmacies. Cost-sharing for other beneficiaries is updated annually; check current Tricare schedules.
The Pharmacy Home Delivery option through Express Scripts produces the lowest cost-sharing for maintenance medications and is particularly suited to chronic therapies like Zepbound.
Tricare for Life and Medicare Part D coordination
Tricare for Life beneficiaries are Medicare-eligible retirees with Tricare as secondary wraparound coverage. Their primary prescription drug coverage is Medicare Part D.
For Zepbound, the coverage interaction:
- Medicare Part D historically excludes weight-loss medications
- The December 2024 OSA indication created a Part D coverage path (sleep medicine, not weight loss)
- Tricare wraparound covers cost-sharing on Part D-covered drugs
- For drugs Part D does not cover, Tricare for Life does not generally provide alternative coverage
Tricare for Life beneficiaries should pursue the OSA indication when applicable. Standalone Part D plans (Wellcare, Aetna, UnitedHealthcare, others) and Tricare coordinate cost-sharing for covered prescriptions.
Humana Military and other regional administrators
Tricare's medical claims and member services are administered by regional contractors:
- Tricare East: administered by Humana Military
- Tricare West: administered by TriWest Healthcare Alliance (effective 2024 contract transition)
- Tricare Overseas: administered by International SOS
These regional contractors handle medical claims, but pharmacy benefits flow through Express Scripts uniformly across regions. A beneficiary in Tricare East has the same pharmacy formulary as a beneficiary in Tricare West.
Appealing a Tricare denial
Tricare pharmacy appeals:
- Internal Express Scripts review
- Reconsideration with additional clinical documentation
- Defense Health Agency appeal for final administrative review
Specific deadlines apply (typically 90 days for standard appeals). Expedited appeals are available for urgent cases.
Appeal strategy for Zepbound denials:
- For OSA indication: include complete polysomnography reports, CPAP trial documentation, sleep medicine physician letter
- For obesity indication: include BMI history, comorbidity documentation, lifestyle intervention participation records
- For active duty: consider command medical officer endorsement
- Cite FDA approvals and clinical trial evidence (SURMOUNT-OSA, SURMOUNT-1)
Decision framework
If you are active duty with BMI 30+ or 27+ with comorbidities: Coordinate with command medical officer before initiating PA. Discuss readiness implications. Submit PA through military physician.
If you are a retiree, dependent, or family member: Standard PA pathway. Use Tricare Pharmacy Home Delivery for lowest cost-sharing.
If you have type 2 diabetes: Pursue Mounjaro under the diabetes indication. Same molecule, more accessible coverage.
If you have moderate-to-severe OSA: The OSA indication is your strongest coverage pathway. Sleep medicine documentation is essential.
If you are Tricare for Life: Coordinate between Medicare Part D plan and Tricare wraparound. OSA indication is your most accessible pathway for Zepbound.
If denied: File reconsideration with Express Scripts. Appeal to DHA. Strengthen documentation.
What to verify before using this answer
The useful next step for Tricare and Zepbound: The Military Health System Coverage Map is to verify the details that can change the decision: current labeling, insurance rules, pharmacy instructions, dose timing, contraindications, and whether the evidence applies to your diagnosis rather than only to weight loss headlines.
For this coverage and access page, the most relevant search terms are does, tricare, cover, zepbound. Those terms point to a practical decision, so the answer should be checked against a current prescription label, payer policy, trial result, or clinician recommendation before you act.
FormBlends keeps this page focused on patient-level decision points: what is known, what is uncertain, what should be handled by a licensed clinician, and what should be avoided because it creates dosing, safety, or access risk.
FAQ
Does Tricare cover Zepbound? Yes, with PA for eligible beneficiaries.
Who handles Zepbound prescriptions at Tricare? Express Scripts under DoD contract.
What is the Tricare prior authorization for Zepbound? BMI, comorbidities, lifestyle intervention, or for OSA, sleep study and CPAP trial.
How much does Zepbound cost with Tricare? Active duty $0. Others approximately $14 to $76 depending on pharmacy choice.
Does Tricare cover Zepbound for sleep apnea? Yes, OSA indication incorporated since December 2024.
Are there active-duty considerations for Zepbound? Operational readiness intersections; coordinate with command medical officer.
Can dependents access Zepbound through Tricare? Yes, same PA criteria as sponsor.
What about Mounjaro for diabetic Tricare members? Yes, covered with PA; same molecule, more accessible coverage than Zepbound for obesity.
Sources
- FDA, Zepbound (tirzepatide) prescribing information, OSA label expansion, December 2024
- Malhotra A et al. Tirzepatide for Obstructive Sleep Apnea (SURMOUNT-OSA). New England Journal of Medicine. June 2024
- Jastreboff AM et al. SURMOUNT-1 trial. New England Journal of Medicine. 2022
- Tricare Pharmacy Program Formulary, administered by Express Scripts, 2026 edition
- Defense Health Agency, Tricare beneficiary materials
- Department of Defense Pharmacy and Therapeutics Committee, GLP-1 coverage policies
- Tricare cost-sharing schedule, 2026 plan year
- Humana Military, Tricare East Region administration materials
- TriWest Healthcare Alliance, Tricare West Region administration materials
- Service-specific weight management and fitness program publications
- Centers for Medicare and Medicaid Services, Part D and Tricare for Life coordination guidance
Footer disclaimers
Platform Disclaimer. FormBlends is a telehealth platform connecting patients with licensed clinicians and 503A compounding pharmacy partners. FormBlends is not affiliated with Tricare, the Department of Defense, Defense Health Agency, Express Scripts, Humana Military, TriWest Healthcare Alliance, or Eli Lilly. Coverage information reflects publicly available data as of May 2026.
Compounded Medication Notice. Compounded tirzepatide is a 503A pharmacy product, not FDA-approved, and not interchangeable with brand-name Zepbound. Tricare does not cover compounded medications. Active duty service members should consult command medical officer before using compounded medications outside the Tricare formulary.
Results Disclaimer. Weight loss, AHI reduction, and metabolic outcomes from clinical trial data reflect average effects in study populations. Individual response varies. Service members should consider that medication use is one component of broader fitness and readiness assessments.
Trademark Notice. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Tricare is a registered service mark of the United States Department of Defense. Express Scripts is a registered trademark of Express Scripts Holding Company. References are informational.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →